Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Sodium Fluoride



What is Denti-Care Denti-Rinse?

AMD Medicom Inc.

DentiCare Pro-Rinse

2% Neutral Sodium Fluoride Oral Rinse


1.9 L / 64 fl oz

NDC 64778-0448-1

NPN 80008542

Rx Only in US

Item code 10044-B

What does Denti-Care Denti-Rinse look like?

What are the available doses of Denti-Care Denti-Rinse?

Sorry No records found.

What should I talk to my health care provider before I take Denti-Care Denti-Rinse?

Sorry No records found

How should I use Denti-Care Denti-Rinse?

Directions: Dispense 10mL of solution into a measuring cup. Instruct patient to rinse vigorously for 60 seconds, around and in between teeth, then expectorate. For maximum benefit repeat the rinse procedure with an additional 10mL

Advise patient not to eat, drink or rinse for 30 minutes after application

Pro-Rinse solution may also be applied with a cotton tip applicator to teeth isolated with cotton rolls

Medicinal ingredients: Sodium fluoride 2.0% w/w

What interacts with Denti-Care Denti-Rinse?

Sorry No Records found

What are the warnings of Denti-Care Denti-Rinse?

Sorry No Records found

What are the precautions of Denti-Care Denti-Rinse?

Sorry No Records found

What are the side effects of Denti-Care Denti-Rinse?

Sorry No records found

What should I look out for while using Denti-Care Denti-Rinse?

What might happen if I take too much Denti-Care Denti-Rinse?

Sorry No Records found

How should I store and handle Denti-Care Denti-Rinse?

Sorry No Records found


Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Non-Clinical Toxicology
The pharmacokinetic interactions listed below are potentially clinically important. Mutual inhibition of metabolism occurs with concurrent use of cyclosporin and methylprednisolone; therefore, it is possible that adverse events associated with the individual use of either drug may be more apt to occur. Convulsions have been reported with concurrent use of methylprednisolone and cyclosporin. Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of methylprednisolone and may require increases in methylprednisolone dose to achieve the desired response. Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of methylprednisolone and thus decrease its clearance. Therefore, the dose of methylprednisolone should be titrated to avoid steroid toxicity.

Methylprednisolone may increase the clearance of chronic high dose aspirin. This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when methylprednisolone is withdrawn. Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia.

The effect of methylprednisolone on oral anticoagulants is variable. There are reports of enhanced as well as diminished effects of anticoagulant when given concurrently with corticosteroids. Therefore, coagulation indices should be monitored to maintain the desired anticoagulant effect.

KEEP OUT OF REACH OF CHILDREN. For professional use only

Not recommended for use by children under 6 years of age. Do not swallow

Store at room temperature. Do not expose to excessive heat over 40ºC or 104ºF

Do not use if seal is broken



This information is obtained from the National Institute of Health's Standard Packaging Label drug database.

While we update our database periodically, we cannot guarantee it is always updated to the latest version.



Rate this treatment and share your opinion

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment


Click the stars to rate this treatment

This medication has worked for me.

This medication has been easy for me to use.

Overall, I have been satisfied with my experience.

Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:


Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72






A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).